SNTA1 and breast cancer: As shown in the results above, SNTA1/p66Shc signaling axis contributed to RhoA activation in metastatic breast cancer cells; whereas cytochalasin D mediated actin depolymerization destabilized this transduction axis reducing RhoA activation levels in these cells.